Liang Haijie, Zang Jie, Huang Siyi, Wang Boyang, Tang Shun, Du Zhiye, Qi Feiyang, Guo Wei, Wang Jichuan, Tang Xiaodong
Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China.
Front Bioeng Biotechnol. 2025 Jun 11;13:1547652. doi: 10.3389/fbioe.2025.1547652. eCollection 2025.
Bone defects resulting from sarcoma resection in the forearm present significant challenges for reconstruction, with limited guidance available in the literature.
We developed a novel series of 3D-printed endoprostheses, called the Global Forearm Reconstruction System (GFRS), to reconstruct defects of the proximal radius (PR), distal ulna (DU), total ulna (TU), and total radius (TR). Finite element analysis (FEA) was performed to determine the mechanical support function of the GFRS endoprostheses. We also tested the rotatory function of the endoprostheses using a resin model. Finally, we summarized the preliminary outcomes of three pediatric cases using the GFRS endoprostheses for reconstruction.
Resection of PR, DU, TU and TR leads to stress concentration in the remaining structures, which can be mitigated by the corresponding GFRS endoprostheses. The novel endoprostheses demonstrated full supination capability and approximately 50% of pronation in the model. All of the three clinical cases achieved satisfactory functional status (MSTS-93:28-29; MEPS: 95-100) without complications during mid-term follow-up (32-42 months).
In this proof-of-concept study, we demonstrated that the GFRS endoprostheses not only meet the theoretical reconstruction requirements but also exhibit a good safety profile and produce satisfactory functional outcomes in a preliminary cohort with mid-term follow-up.
前臂肉瘤切除术后导致的骨缺损给重建带来了重大挑战,而文献中可用的指导有限。
我们开发了一系列名为全球前臂重建系统(GFRS)的新型3D打印假体,用于重建桡骨近端(PR)、尺骨远端(DU)、全尺骨(TU)和全桡骨(TR)的缺损。进行有限元分析(FEA)以确定GFRS假体的机械支撑功能。我们还使用树脂模型测试了假体的旋转功能。最后,我们总结了三例使用GFRS假体进行重建的儿科病例的初步结果。
PR、DU、TU和TR的切除会导致剩余结构中的应力集中,而相应的GFRS假体可以减轻这种应力集中。新型假体在模型中显示出完全旋后能力和大约50%的旋前能力。所有三例临床病例在中期随访(32 - 42个月)期间均获得了满意的功能状态(MSTS - 93:28 - 29;MEPS:95 - 100),且无并发症。
在这项概念验证研究中,我们证明了GFRS假体不仅满足理论重建要求,而且在中期随访的初步队列中显示出良好的安全性和令人满意的功能结果。